PCSK9 and familial hyperaldosteronism: Many non-statin medications, including ezetimibe, PCSK9 inhibitors, mipomersen, and lomitapide, efficiently regulate cholesterol levels and might be prescribed as monotherapy or combination therapy in FH patients [44,49,50,51,52,53].